218 related articles for article (PubMed ID: 37541790)
1. Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism.
Vahabi M; Comandatore A; Franczak MA; Smolenski RT; Peters GJ; Morelli L; Giovannetti E
Cytokine Growth Factor Rev; 2023 Oct; 73():163-172. PubMed ID: 37541790
[TBL] [Abstract][Full Text] [Related]
2. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.
Achreja A; Zhao H; Yang L; Yun TH; Marini J; Nagrath D
Metab Eng; 2017 Sep; 43(Pt B):156-172. PubMed ID: 28087332
[TBL] [Abstract][Full Text] [Related]
3. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
4. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
[TBL] [Abstract][Full Text] [Related]
5. Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.
Sharma A
Nanomedicine (Lond); 2017 Sep; 12(17):2137-2148. PubMed ID: 28805111
[TBL] [Abstract][Full Text] [Related]
6. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer.
Fan J; Wei Q; Koay EJ; Liu Y; Ning B; Bernard PW; Zhang N; Han H; Katz MH; Zhao Z; Hu Y
Theranostics; 2018; 8(21):5986-5994. PubMed ID: 30613276
[No Abstract] [Full Text] [Related]
7. Exosomes carrying ALDOA and ALDH3A1 from irradiated lung cancer cells enhance migration and invasion of recipients by accelerating glycolysis.
Wang C; Xu J; Yuan D; Bai Y; Pan Y; Zhang J; Shao C
Mol Cell Biochem; 2020 Jun; 469(1-2):77-87. PubMed ID: 32297178
[TBL] [Abstract][Full Text] [Related]
8. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
[TBL] [Abstract][Full Text] [Related]
9. Enigmatic exosomal connection in lung cancer drug resistance.
Patra SK; Sahoo RK; Biswal S; Panda SS; Biswal BK
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102177. PubMed ID: 38617976
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis.
Zeng Z; Zhao Y; Chen Q; Zhu S; Niu Y; Ye Z; Hu P; Chen D; Xu P; Chen J; Hu C; Hu Y; Xu F; Tang J; Wang F; Han S; Huang M; Wang C; Zhao G
Oncogene; 2021 Sep; 40(36):5505-5517. PubMed ID: 34294845
[TBL] [Abstract][Full Text] [Related]
11. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
12. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma.
Zhang J; Song Q; Wu M; Zheng W
Curr Med Chem; 2021; 28(1):93-109. PubMed ID: 32000636
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and Signaling Functions of Cancer Cell-Derived Extracellular Vesicles.
Fonseca P; Vardaki I; Occhionero A; Panaretakis T
Int Rev Cell Mol Biol; 2016; 326():175-99. PubMed ID: 27572129
[TBL] [Abstract][Full Text] [Related]
15. Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment.
Xu W; Weng J; Xu M; Zhou Q; Liu S; Hu Z; Ren N; Zhou C; Shen Y
Cell Reprogram; 2023 Jun; 25(3):91-98. PubMed ID: 37172278
[TBL] [Abstract][Full Text] [Related]
16. Exosome: a novel mediator in drug resistance of cancer cells.
Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhu LP; Wang DD; Zhou SY; Yang SJ; Wang JY; Zhang Q; Xu HZ; Zhao JH; Ji ZL; Tang JH
Epigenomics; 2018 Nov; 10(11):1499-1509. PubMed ID: 30309258
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles in Cancer Metabolism: Implications for Cancer Diagnosis and Treatment.
Zhang Q; Yang X; Liu H
Technol Cancer Res Treat; 2021; 20():15330338211037821. PubMed ID: 34427131
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy.
Guo W; Qiao T; Dong B; Li T; Liu Q; Xu X
Front Immunol; 2022; 13():915985. PubMed ID: 35812406
[TBL] [Abstract][Full Text] [Related]
19. Exosomes from glioma cells induce a tumor-like phenotype in mesenchymal stem cells by activating glycolysis.
Ma Z; Cui X; Lu L; Chen G; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X
Stem Cell Res Ther; 2019 Feb; 10(1):60. PubMed ID: 30770778
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation.
Papadakos SP; Machairas N; Stergiou IE; Arvanitakis K; Germanidis G; Frampton AE; Theocharis S
Cells; 2023 Aug; 12(16):. PubMed ID: 37626849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
